healthcare market

The global life science instrumentation market size is projected to grow from an estimated USD 60.0 billion in 2020 to USD 79.9 billion by 2025, at a CAGR of 5.9% during the forecast period.

Market growth is driven largely by factors, such as increasing expenditure on research & development by pharmaceutical & biotechnology companies, growing public & private funding for life science research, and rising incidence of target diseases & genetic disorders. The emerging markets and increasing demand for analytical instruments are expected to present avenues of growth for market players.

Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=38

The research application segment was the largest contributor to the life science instrumentation market in 2019

The research application segment accounted for the largest share of the life science instrumentation application market in 2019. The large share of the research applications segment can be attributed to evolving global regulatory scenarios for research data publication in analytical instruments-based researches, an increasing number of research studies coupled with growing public-private funding in the field of genomic researches, and the ongoing trend of laboratory automation & integration of robotics.

Next-generation sequencing (NGS) to register the highest growth over the forecast period among life science instrumentation technologies

The Next-generation sequencing (NGS) segment is expected to register the highest growth over the forecast among the life science instrumentation technologies market over the forecast period. The significant growth of this segment is attributed to the advantages offered by NGS technologies in DNA sequencing, which substantially provides more throughput and minimizes the need for fragment-cloning methods. In addition, continuous technological advancements and the increasing availability of cheaper sequencing platforms

Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=38

Asia Pacific is expected to grow at the highest CAGR in the life science instrumentation market during the forecast period

The Asia Pacific is one of the major revenue-generating regions in the life science instrumentation industry. The strategic expansions by key market players in emerging Asian countries, the growing pharmaceutical industry in India & China, and conferences, exhibitions, & meetings on analytical instruments is driving growth in the region.

Key Market Players

Agilent Technologies (US), Becton, Dickinson, and Company (US), Bio-Rad Laboratories, Inc. (US), Bruker Corporation (US), Danaher Corporation (US), Eppendorf AG (Germany), GE Healthcare (US), Hitachi High-Technologies Corporation (Japan), Horiba (Japan), Merck KGaA (Germany), PerkinElmer, Inc. (US), Qiagen N.V. (Netherlands), Shimadzu Corporation (Japan), Thermo Fisher Scientific, Inc. (US), and Waters Corporation (US).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

[134 pages Report] The aspiration and biopsy needles market is estimated to grow at a CAGR of 7.3% to reach USD 1,272 Million by 2024 from USD 894 Million in 2019.

Factors such as the rising prevalence of cancer, initiatives undertaken by government and global health organizations, and the increasing preference for minimally invasive procedures are the major factors driving the growth of the aspiration and biopsy needle market.

Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=71036825

By site, the breast segment held the largest share of the market in 2019.          

On the basis of site, the aspiration needles market is segmented into breast, lung, colorectal, prostate, kidney, and bone & bone marrow. In 2019, the breast cancer segment accounted for the largest share of the market. The large share of this segment is mainly attributed to the rising prevalence of breast cancer, growing awareness about the disease, and increasing research activity pertaining to breast screening and diagnosis.

Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=71036825

Image-guided procedures accounted for the largest share of the Biopsy Needles Market, by procedure

On the basis of procedure, the Aspiration Needles Market is segmented into image-guided procedures (ultrasound-guided biopsy, stereotactic-guided biopsy, MRI-guided biopsy, and other image-guided procedures) and nonimage-guided procedures. Image-guided procedures accounted for the largest share of this market in 2018, primarily due to the provision of accuracy provided by it in locating the mass of cells and liquid hence helping it in accuracy for diagnosis.

North America accounted for the largest share of the aspiration and biopsy needles market in 2019

This report covers the biopsy needles market across four major geographies—North America, Europe, Asia Pacific, and the Rest of the World. North America commanded the largest share of the fine needle aspiration market in 2019. Factors such as the increasing prevalence of cancer in the US and Canada and cancer awareness initiatives undertaken by local governments and global health organizations in the North America region are the key factors driving market growth.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Key Market Players:

The key players operating in the global Aspiration & Biopsy Needles Market are CONMED Corporation (US), Medtronic Plc (Ireland), Olympus (Japan), Becton, Dickinson and Company (US), Boston Scientific Corporation (US), Cook Group Incorporated (US), Argon Medical Devices, Inc (US), INRAD Inc. (US), Somatex Medical Technologies (Germany), Stryker Corporation (US), Cardinal Health (US), Remington Medical (US), HAKKO CO.,LTD (Japan), and Merit Medical Systems (US)

[147 Pages Report] The healthcare asset management market is expected to reach USD 35.19 billion by 2023 from USD 6.89 billion in 2017, at a CAGR of 31.4%.

The growth of the RFID Market is driven by need for better asset management in hospitals, acceptance of asset management solutions in the pharmaceutical industry, and decline in prices of RFID Tags.

Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1195

RFID Tags segment is expected to dominate the RFID products market in 2018.

Based on type, the Hospital Asset Management Market is segmented into tags, readers/interrogators, antennas, and accessories. In 2018, the RFID tags segment is expected to dominate the market. The growth of Drug Counterfeit Market is attributed to the increasing acceptance of RFID in pharmaceutical companies, declining prices of RFID tags, and the availability of technologically advanced products in the IR Market.

Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=1195

Based on type, the passive RFID tag segment is projected to grow at the highest CAGR during the forecast period.

Based on type, Pharmaceutical Asset Management Market is segmented into passive tags and active tags. In 2018, the passive RFID segment is expected to account for the largest share of the market; also, this segment is expected to register highest CAGR during the forecast period owing to the low cost of passive tags in comparison with active tags. Also, passive tags do not require an external source of energy, owing to which they are more widely adopted.

North America to dominate the healthcare asset market in 2018

In 2018, North America is expected to dominate the Ultrasound Market followed by Europe. The large share of this region is attributed to factors such as growing patient safety concerns, acceptance of healthcare asset management solutions in hospitals, increasing need to tackle drug counterfeiting, technologically advanced products, and the presence of key players in the region.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Key Market Players:

The key players operating in the global Hospital Asset Management Market are AiRISTA Flow (US), Elpas (US), CenTrak, Inc.(US), ThingMagic [A Novanta Company (US], Sonitor (Norway), Stanley Healthcare (US), Versus Technology, Inc. (US), Zebra Technologies (US), GE Healthcare (US), and IBM Corporation (US).

Growth in the advanced visualization market can be attributed to factors such as technological advancements in the field of AV software, integration of AV software into PACS, improved diagnostic interpretation with AV tools, and development of novel AV solutions.

The Advanced Visualization Market is expected to reach USD 3.19 Billion by 2021 from USD 1.89 Billion in 2016; growing at a CAGR of 11.0% from 2016 to 2021.

By product, the hardware & software segment is expected account for the largest share

Based on product, the global advanced visualization market is segmented into hardware & software and services (further sub-segmented into implementation, post-sales and maintenance, consulting/optimization, and training & education services). In 2017, the hardware & software segment is expected to account for the largest share of the market owing to factors such as development of technologically advanced software, rising adoption of AV solutions in hospitals and diagnostic centres to streamline and increase workflow efficiency, and growing adoption of AV solutions due ease of integrating them into PACS.

Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=111936030

By type of solution, the enterprise-wide client-based and standalone workstation-based solutions segment is expected account for the largest share

Based on type of solution, the global advanced visualization market is divided into s enterprise-wide client-based and standalone workstation-based solutions. The enterprise-wide client-based and standalone workstation-based solutions segment is expected to account for the largest share of the market in 2016. The large share of this segment can be attributed to factors such as due to offered benefits such as enhanced data storage capacity, data transfer capabilities, multi-user interface, streamlined analysis, and centralized post-processing solutions.

Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=111936030

North America is expected to account for the largest share of the advanced visualization market during the forecast period

The report covers the advanced visualization industry  across four key geographies, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the global advanced visualization market in 2016. Commercialization of advanced diagnostic products, robust R&D infrastructure across the U.S. & Canada, and high prevalence of target diseases are the factors that drive the demand growth of advanced visualization products in the region. The Asia Pacific region is expected to grow at the highest CAGR due to the rapid expansion of healthcare infrastructure in the region, increasing public awareness related to benefits of advanced diagnostic techniques in effective disease management, and rising market penetration of advanced diagnostic technologies.

Key Market Players

General Electric Company (US), Siemens AG (Germany), Koninklijke Philips N.V. (Netherlands), Toshiba Corporation (Japan), and Terarecon, Inc. (US). Other players include Fujifilm Holdings Ltd. (Japan), Agfa HealthCare NV (Belgium), Carestream Health, Inc. (US), Qi Imaging (US), and Visage Imaging, Inc. (US).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Increasing research activities for the development of novel medical ceramics, growing demand for medical ceramics in plastic surgeries & wound healing applications; the rising number of hip & knee replacement procedures; and the increasing demand for implantable devices are responsible for the significant growth of the electrophysiology market during the review period.

[ 187 Pages Report] The global medical ceramics market is projected to reach USD 12.9 billion by 2025 from USD 9.6 billion in 2020, growing at a CAGR of 5.9% from 2020 to 2025.

Request a Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=237425129

“Hydroxyapatite: The largest segment of bioactive ceramics market”

Based on type, the global bioactive ceramics market is segmented into hydroxyapatite and glass ceramics. In 2019, the hydroxyapatite segment accounted for the largest share of the global bioactive ceramics market. This segment is also expected to grow at the highest rate during the forecast period. Hydroxyapatite has high biocompatibility, bioactivity, and osteoconductivity; making it suitable for a wide range of applications, such as a bone void filler for the orthopedic, spine, maxillofacial, and dental surgery; restoration of periodontal defects; orthopedic and dental implant coating; bone-tissue engineering; and gene delivery. Due to its bioactivity, hydroxyapatite is an alternative to allogenic & xenogeneic bone grafts, resulting in shorter healing times. Additionally, it is used as an injectable cement or coating on titanium & titanium alloy implants to reduce the implant rejection rate.

To know about the assumptions considered for the study, download the pdf brochure

Dental applications segment is anticipated to hold major share of the global medical ceramics market in terms of application

Based on application, the global medical ceramics market is broadly segmented into dental applications, orthopedic applications, cardiovascular applications, surgical instruments, diagnostic instruments, plastic surgery, and other applications (cancer, dialysis, drug delivery systems, and gene therapy). The dental applications segment accounted for the largest share of the medical ceramics market in 2019. This segments large share can be attributed to the increasing number of cosmetic dental procedures and dental implant procedures across various regions and rising periodontal disorders.

Asia Pacific market to register highest growth for the Dental implants medical ceramic market

The bioinert ceramics market in Asia Pacific, particularly in China, Japan, and India, is expected to witness high growth in the coming five years. The medical ceramics market in the APAC is estimated to grow rapidly during the forecast period, considering the development of the region's healthcare sector. The major consumers of medical ceramics in the APAC are China, South Korea, and Japan. The aging population, increasing disposable income, technological advancements, and growing awareness about treatments available provide huge growth opportunities for HAp manufacturers in the region. The factors widening the opportunity for medical ceramics manufacturers are the presence of a large aging population in China and India and Japan's existence as the second-largest healthcare market in the world. Moreover, the distinction of South Korea as the plastic surgery capital of the world offers opportunities for the market players.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=237425129

Key Market Players:

The major players operating in the medical ceramics market are are CoorsTek, Inc. (US), CeramTec GmbH (Germany), KYOCERA Corporation (Japan), Morgan Advanced Materials (UK), Tosoh (Japan), Johnson & Johnson (US), Institut Straumann (Switzerland), 3M (US), Royal DSM (DSM) (Netherlands), Rauschert GmbH (Germany), Zimmer Biomet (US), NGK Spark Plug (Japan), H.C. Stark GmbH (Germany), Berkeley Advanced Biomaterials (US), Nobel Biocare Services (Switzerland), Kuraray Noritake Dental (Japan), Ferro Corporation (Japan), APC International (US), TRS Technologies (US), QSIL Ceramics (Germany), Washington Mills (US), CAM Bioceramics (The Netherlands), CaP Biomaterials (US), Admatec (The Netherlands), and BCE Special Ceramics (Germany).

The study involved four major activities to estimate the current market size for sports medicine. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter market breakdown and data triangulation was used to estimate the market size of segments and subsegments

Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=751

Major Market Growth Drivers:

Growth in the Body Recovery Market is primarily driven by factors such the increasing incidences of sports injuries, continuous influx of new products & treatment modalities, developments in the field of regenerative medicine, rising demand for minimally invasive surgeries.

Revenue Growth Analysis:

The sports medicine market is expected to grow from USD 5.5 billion in 2020 to USD 7.2 billion by 2025, at a CAGR of 5.7% during the forecast period.

Browse and in-depth TOC on" Sports Medicine Market"

245 – Tables
38 – Figures
266 – Pages

Body support & recovery products expected to grow at the highest rate during the forecast period

On the basis of products, the Body Recovery Market is segmented into body reconstruction products (fracture & ligament repair products, arthroscopy devices, implants, prosthetics, orthobiologics), body support & recovery products (braces & support, physiotherapy equipment, and compression clothing), and accessories. The body support & recovery products segment is expected to witness the fastest growth during the forecast period.

Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=751

The Hospitals segment is expected to account for the largest share during the forecast period.

Based on end user segment, the Sports medicine products market is segmented into Hospitals, Ambulatory Surgery centres and Physiotherapy Centres and Clinics. The hospitals segment accounted for the largest share of the sports medicine market.  The large share of this segment can be attributed to factors like Complex diagnostic and therapeutic procedures being carried out in hospitals.

North America is expected to dominate the sports medicine products market during the forecast period

Geographically, North America is expected to dominate the global sports medicine devices market in 2018, while the Asia Pacific region is expected to register the highest CAGR during the forecast period. The high growth in this region can be attributed to the growth of the sports industry and overall participation in sports. Sporting events such as the 2008 Beijing Olympics, 2018 Winter Olympics in Korea, and the upcoming 2020 Summer Olympics in Japan have increased the level of interest in sports in Asia.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Key Orthopedic Bracing Market Players:

The key players operating in the global Orthopedic Bracing Market are Arthrex, Inc (US), Smith & Nephew plc (UK), Stryker Corporation (US), Breg Inc. (US), DJO Global, Inc. (US), Mueller Sports, Inc. (US), Wright Medical Group N.V. (US), Medtronic (Ireland), RTI Surgical (US), Performance Health International Limited (US), KARL STORZ (Germany), and Bauerfeind AG (US), Össur (Iceland), MedShape (US), Cramer Products (US),  Biotek ( India), RôG Sports Medicine (US).

The research study involves four major activities in estimating the current size of the tissue diagnostic market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Then, both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1063949

Major Market Growth Drivers:

This industry is experiencing significant growth due to the rising incidence of cancer, developing infrastructure for cancer diagnosis, recommendation of cancer screening, availability of reimbursements, and increasing healthcare expenditure.

Revenue Growth Analysis:

The global tissue diagnostics market size is expected to reach USD 4.7 billion by 2025 from USD 3.4 billion in 2020, at a CAGR of 6.5%.

Browse and in-depth TOC on" Tissue Diagnostics Market"

127 – Tables
38 – Figures
174 – Pages

Consumables segment to dominate the Tissue diagnostics product market in 2019

Based on the product, the tissue diagnostics market is segmented into instruments and consumables. The consumables segment is expected to grow at the highest growth rate during the forecast period. This is attributed primarily to their requirement in large numbers, cost-effectiveness, and ease of use. The increasing number of reagent rental agreement is also one of the major factors to drive the growth of the consumables market globally

Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=1063949

Immunohistochemistry segment to dominate the tissue diagnostics market in 2019

Based on the technology, the Tissue diagnostics product market is segmented into immunohistochemistry, in situ hybridization, digital pathology and workflow, and special staining. The immunohistochemistry segment is estimated to register the highest CAGR during the forecast period. This can primarily be attributed to the increasing prevalence of chronic diseases across the globe, where this technology is mostly used in tissue diagnostics.

North America was the largest regional for tissue diagnostic market in 2019

The tissue diagnostics product market has been analyzed for North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2019, North America held the largest share of the market, followed by Europe. Easy accessibility to advanced technologies, government initiatives for screening cancer patients, favourable reimbursement scenario for pathology diagnostic tests, increasing healthcare expenditure, and high-quality infrastructure for hospitals and clinical laboratories in this region are the major factors driving the growth of the tissue diagnostic market in North America.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Key Market Players:

The key players operating in the global Tissue diagnostics product market are Roche (Switzerland), Danaher (US), Thermo Fisher Scientific (US), Abbott (US), Agilent Technologies (US), ABCAM (UK), Merck KGAA (Germany), BD (US), Hologic (US), Bio Rad (US), Biomeriux (France), Sakura Fientek Japan (Japan), BioSB (US), Biogenex (US), Cell Signaling Technology (US), Histoline Laboratories (Italy), Slee Medical GMBH (Germany), Amos Scientific PTY Ltd (Australia), Jinhua Yidi Medical Appliance Co.Ltd (China), Medite GMBH (Germany), Cellpath Ltd(UK), and Dipath S.P.A. (Italy).

[183 Pages Report] The global veterinary ultrasound market size is projected to reach USD 448 million by 2025 from USD 338 million in 2020, at a CAGR of 5.8%.

Factors such as growth in the companion animal population, rising demand for pet insurance, increasing number of veterinary practitioners in developed economies, technological advancements are driving the growth of this market during the forecast period. However, high cost of instruments and procedures is restraining the growth of Animal Ultrasound Market to some extent.

Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=10482074

The 2D ultrasound segment dominates the veterinary ultrasound industry, by type of ultrasound scanners

Based on the type of scanners, the 2D segment accounted for the largest share of the veterinary ultrasound market in 2019. The large share of this segment can primarily be attributed to the widespread popularity of these type of scanners in disease diagnosis as well as in pregnancy detection.

By product, the cart-based segment accounted for the largest share of the market in 2019

Based on product, the Animal Ultrasound Market is segmented into cart-based and portable ultrasound scanners. In 2019, the cart-based segment accounted for the largest portion of the market due to its ease of use and is extensively used in hospitals, clinics and diagnostic centers.

Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=10482074

North America will continue to dominate the Animal Ultrasound Market during the forecast period

The Animal Ultrasound Market, by region, is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share of the animal/veterinary ultrasound industry in 2019. The growth of the North American market is attributed to the increasing adoption of companion animals, the growing pet insurance industry, rising veterinary healthcare expenditure, and the growing number of veterinary practices. In addition, a majority of players in the animal/veterinary ultrasound industry are based in the US.

Key Market Players:

The key players operating in the global Veterinary Ultrasound Market are GE Healthcare (US), Heska Corporation (US), Siemens AG (Germany), FUJIFILM Holdings Corporation (Japan), Esaote SpA (Italy), Mindray Medical International, Ltd. (China), Samsung Medison Co., Ltd.( Korea), Diagnostic Imaging Systems Inc. (US), IMV imaging (Scotland), Shenzhen Ricso Technology Co., Ltd. (China), DRAMIÑSKI S.A. (Poland), Shantou Institute of Ultrasonic Instruments Co., Ltd. (SIUI), Clarius Mobile Health (US) and SonoScape Medical Corporation  (China)

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Major Market Growth Drivers:

The global bioprocess containers market is expected to reach USD 1,914.6 million by 2023 from USD 913.3 million in 2017, at a CAGR of 13.2%.

Growth in the bioprocess containers market is mainly driven by factors such as the increasing demand for biologics, affordability and sustainability of single-use bioprocess technologies, vaccine production using single-use disposable technologies, and the lower risk of cross-contamination.

Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=107645832

Upstream Process segment dominated the Bioprocess Containers Market in 2018

Based on application, the bioprocess containers market is segmented into process development, upstream processes, and downstream processes. In 2017, the upstream process segment accounted for the largest share of the bioprocess containers market. Upstream processes make the highest use of bioprocess containers, especially during fermentation, mixing, and culture media processing; due to this, this segment holds the largest market share.

Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=107645832

Biopharmaceutical Companies is expected to account for the largest share for Bioprocess Containers Market

Based on end user, the bioprocess containers market is segmented into biopharmaceutical companies and life science R&D companies. The biopharmaceutical companies’ segment is expected to dominate the market during the forecast period, while the life science R&D companies segment is expected to grow at the highest CAGR. Biopharmaceutical manufacturing is generally characterized using single-use technologies including bioprocess containers. Bioprocess container systems, due to their cost-effectiveness, have found wide use in biopharmaceutical manufacturing as they can lower the overall cost of production. This is the key factor driving market growth for the biopharmaceutical companies’ segment.

North America is estimated to command the largest share of the Bioprocess container Market

North America accounted for the largest share of Biocontainers Market in 2017, followed by Europe. The rising demand for biopharmaceuticals and advantages associated with the use of bioprocess bags such as their energy efficiency, decreased risk of product cross contamination, and fast implementation are driving the adoption of bioprocess containers in North America. The US accounted for the largest share of the North American bioprocess market in 2017. The growing focus on biopharmaceutical production is a major driver for this market. Government support for novel biologics production has triggered R&D activity in the country, thereby making it an attractive destination for biologics manufacturing.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Key Market Players:

Henry Schein (US), IDEXX Laboratories (US), Patterson Companies (US), Vetter Software (US), Animal Intelligence Software (US), Timeless Veterinary Systems (Canada), Brittons Wise Computers (US), ezyVet Limited (New Zealand), FirmCloud Corporation (US), MedaNext (US), OR Technology (Oehm Und Rehbein GmbH, Germany), VIA Information Systems (US), Hippo Manager Software (US), Finnish Net Solutions (Finland), Carestream (Canada), and ClienTrax (US)

The growth of this market is driven by the escalating prevalence of preterm births, favorable government policies, advanced technologies of fetal monitoring systems, and active product launches.

The fetal monitoring market is projected to reach USD 5.2 billion by 2026 from USD 3.7 billion in 2021, at a CAGR of 7.2% from 2021 to 2026.

To know about the assumptions considered for the study, Request for Free Sample Report

“Antepartum is expected to hold the largest share of the fetal monitoring market, by application in 2021.”

Based on application, the fetal heart monitoring market is segmented into antepartum and intrapartum. The antepartum segment accounts for the largest share of the fetal monitoring market. Antepartum fetal monitoring is carried out throughout the gestation period to diagnose any congenital fetal abnormalities. The extensive monitoring regimes, recent product launches, surging prevalence of fetal anomalies, and maternal mortalities drive the growth of the antepartum segment.

Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=35700261

“Hospitals are expected to hold the largest share of the fetal monitoring market, by end user in 2021.”

The fetal heart monitoring market is segmented into hospitals, obstetrics & gynecology clinics, and home care settings based on end users. In 2020, hospitals accounted for the largest share of this market. This segments growth can be attributed to several factors, such as highly advanced facilities in hospitals and the increasing number of pregnancy procedures. Technological advancements, coupled with government funding, are also encouraging the installation of new tools and devices in hospitals, thus supporting market growth.

“North America commanded the largest share of the fetal monitoring market in 2021.”

On the basis of region, the fetal heart monitoring market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. In 2019, North America commanded the largest share of the fetal monitoring market. The large share of this market segment can be attributed to the presence of an established reimbufrsement structure coupled with availability of experts in the North American countries.

Leading Companies

Cardinal Health, Inc. (US), Koninklijke Philips N.V. (Netherlands), GE Healthcare (US), Siemens Healthineers (Germany), FUJIFILM SonoSite, Inc. (US), Natus Medical Incorporated (US), Huntleigh Healthcare Limited (UK), The Cooper Companies Inc. (US), CONTEC Medical Systems Co., Ltd. (China), EDAN Diagnostics, Inc. (China), Neoventa Medical AB (Sweden), Bionet Co., Ltd. (South Korea), Progetti Srl (Italy), TRISMED Co., Ltd. (Republic of Korea), ShenZhen Luckcome Technology Inc. (China), MedGyn Products, Inc (US), Dixion (Germany), Promed Group Co., Ltd. (Hong Kong), Advanced Instrumentations (US), BRAEL-Medical Equipment (Poland), GPC Medical (India), BISTOS (Korea), Mediana (Korea), Life Plus (India), ChoiceMMed (China), Trivitron Healthcare (India), Dott Medical Co. Ltd. (China), Monarch Meditech (India), and Shenzhen Comen Medical Instruments Co., Ltd. (China).

Don’t miss out on business opportunities in Fetal Monitoring Market. Speak to our analyst and gain crucial industry insights that will help your business grow. @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=35700261

The RNA analysis market is projected to reach USD 8.7 billion by 2025 from USD 4.5 billion in 2020, at a CAGR of 13.9% during the forecast period.

The growth of this market is majorly driven by the increasing demand for personalized medicine, increasing pharmaceutical and biotechnology R&D expenditure and government funding for omics, and the increasing applications of RNA sequencing in the transcriptomics market.

The increasing focus on biomarker discovery and toxicogenomics, along with the increasing interest in outsourcing services, is expected to offer significant growth opportunities for the players operating in the global RNA analysis/transcriptomics market. On the other hand, the requirement of high capital investments and data management issues are expected to restrain the growth of this market to a certain extent.

Request for Free Sample Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=240344576

RNA ANALYSIS/ TRANSCRIPTOMICS MARKET DYNAMICS

Driver:  Increasing demand for personalized medicine

Personalized medicine, which has become a core area of research in the healthcare industry, has entered mainstream clinical practice and is changing how many diseases are identified, classified, and treated. These advancements are particularly evident in the area of oncology.

According to the Personalized Medicine Coalition report (2017), the number of personalized drugs, treatments, and diagnostic products has increased since 2006, and this trend is expected to continue in the coming years.

Restraint: High capital investments

With the widespread implementation of novel applications, the use of transcriptomics research extends all the way from the discovery of novel drugs, vaccines, and diagnostic targets, toxicology, and identification of surrogate markers of activity in clinical research to the ability to provide information on the mechanisms of drug action.

Opportunity: Increasing focus on biomarker discovery

Biomarker identification, along with its clinical applications, has simplified drug discovery and development procedures in terms of evaluating the toxicity and efficacy of drugs. Besides, biomarkers for diseases like cancer, CVD, and neurological diseases are playing an integral role in enabling a better understanding of the disease pathway and progression.

To know about the assumptions considered for the study, Download a PDF Brochure

Challenge:  Lack of effective bioinformatics tools

Microarray experiments for transcriptomic studies produce enormous amounts of data. Therefore, researchers typically face problems in the interpretation of results and exploiting available computational power to process said data. Moreover, RNA sequencing data from transcriptomics studies have low genome coverage and high amplification bias, which makes data analysis extremely challenging, especially without effective bioinformatics tools.

North America is expected to account for the largest share of the RNA analysis/transcriptomics market in 2019

In 2019, North America accounted for the largest share of the transcriptomics market, followed by Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The large share of this market segment can be attributed to the increasing development of structure-based drug designs, growing academic and government investments in genomics and proteomics research, high life science research funding, high biopharmaceutical R&D expenditure, and the greater adoption of advanced technologies in North America.

Key Market Players

The prominent players in this market are Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories, Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Illumina, Inc. (US), QIAGEN N.V. (Netherlands), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=240344576

This study involved four major activities in estimating the current market size for breast lesion localization method. Exhaustive research was conducted to collect information on the market as well as its peer and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the number of breast lesion localization procedures and the value market. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.

Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=35768623

Major Market Growth Drivers:

The growth of this market is primarily driven by factors such as the rising incidence of breast cancer, an increasing number of breast cancer surgeries, and growing awareness on the early detection of breast cancer. However, the uncertain regulatory approval process faced by prominent players is hampering the growth of the breast lesion localization methods market.

Revenue Growth Analysis:

[157 Pages Report] The breast lesion localization methods market is expected to grow from 3,974.4 thousands of procedures in 2020 to 5750.9 thousands of procedures by 2025, at a CAGR of 7.5% during the forecast period.

Browse and in-depth TOC on" Breast Lesion Localization Methods Market"

136 – Tables
33 – Figures
157 – Pages

Wire localization accounted for the largest share in the market in the forecast period.

The wire localization segment accounted for the highest share of the procedures market, by type. The large share of this segment is attributed to its accuracy in abnormal tissue localization, minimal removal of normal tissues, minimal scarring, and availability of reimbursement for breast lesion localization devices. The ease of use of wire localization technology and the familiarity of end users with the technology have resulted in its increased adoption.

Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=35768623

Sentinel lymph node identification expected to show the highest growth rate in the forecast period.

On the basis of usage, the Wire localization market is segmented into tumor identification and sentinel lymph node identification. The sentinel lymph node identification segment is expected to grow at the fastest rate in the forecast period, Growth in this segment can be attributed cancer. to the increase in acceptance of SLNB as a first-line diagnostic approach for breast cancer staging, as it is more sensitive and causes less morbidity than traditional techniques for the early staging of breast

The Asia Pacific region holds the largest share in the market during the forecast period of 2020–2025.

Geographically, the Wire localization market is segmented into North America, Europe, the Asia Pacific and Rest of the World. The large share of the Asia Pacific region is due to improving healthcare infrastructure, high government spending on breast cancer research, and rising awareness about the importance of the early detection of breast cancer in several APAC countries. Moreover, increasing focus of prominent players on emerging Asian countries will further support the growth of the market in this region.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Key Wire Localization Market Players:

The key players operating in the global breast lesion localization methods market include Becton, Dickinson and Company (US), Endomagnetics Limited (UK), SOMATEX Medical Technologies GmbH (Germany), Cianna Medical (US), Leica Biosystems (US) and IZI Medical Products (US).

According to the latest research report “Healthcare Supply Chain Management Market by Component (Software, Inventory, Order, Warehouse, Purchase, Implant, Transport, Strategic Sourcing, Consignment, Hardware, Barcode, Scanner, RFID), Delivery (On Premise,Cloud), End User - Global Forecast to 2025”

[161 Pages Report] The global healthcare supply chain management market is projected to reach USD 3.3 billion by 2025 from USD 2.2 billion in 2020, at a CAGR of 7.9% during the forecast period.

The key factors driving the growth of this market include the adoption of GS1 system of standard in the healthcare industry globally, the emergence of cloud-based solutions, reduction in operational costs by improving the efficacy and increase in overall profitability.

What drives the market?

• Increasing pressure on healthcare providers to improve operational efficiency and profitability
• Implementation of the UDI initiative by the FDA
• Emergence of cloud-based solutions
• Adoption of the GS1 system of standards
• Continuous support in the form of funding, investments, and partnerships
• Large-scale drug counterfeiting in the pharmaceutical industry

However, the high cost of implementation of supply chain management software is expected to restrict market growth to a certain extent.

Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=77439622

The market in North America is projected to witness the highest growth rate during the forecast period (2020–2025).

North America is projected to register the highest growth during the forecast period. This large share can be attributed to factors such as the consolidation of hospitals, rising prevalence of chronic diseases, and growing awareness in the region. On the other hand, the European region is expected to grow at the second-highest CAGR during the forecast period, followed by APAC and later ROW.

Key Market Players

The healthcare supply chain management market is fragmented, with the presence of several large as well as emerging players. In 2019, SAP SE (Germany), Oracle Corporation (US), and Infor (US) were the leading players in the healthcare supply chain management industry. Other players include McKesson Corporation (US), TECSYS (US), Global Healthcare Exchange (US), Cardinal Health (US), Determine (US), Epicor (US), LLamasoft (US), Manhattan Associates (US), Blue Yonder Group, Inc. (JDA Software) (US), Cerner (US), Jump Technologies (US),  LogiTag Systems (US), Harris Affinity (US), Premier (US), Accurate Info Soft (US), Hybrent (US), and Arvato Systems (Germany).

Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=77439622

Recent Developments

• In 2020, Infor acquired Intelligent InSite.
• In 2019, Oracle launched Intelligent Track and Trace, a blockchain application
• In 2019, SAP SE partnered with Microsoft Corporation, to improve consumer adoption of SAP Cloud Platform and SAP S/4 HANA on Microsoft Azure.

The research study involves four major activities in estimating the current size of the global specialty PACS market. Exhaustive secondary research was done to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing values with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.

Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=66166054

Major Market Growth Drivers:

The growth in Orthopedics PACS Market is driven mainly by the increasing geriatric population and subsequent growth in the incidence of various diseases, advantages associated with specialty PACS, government initiatives to increase the adoption of healthcare IT solutions, growing investments in medical imaging, rising adoption of medical imaging IT solutions, and increasing use of imaging equipment. On the other hand, budgetary constraints are expected to limit market growth during the forecast period.

Revenue Growth Analysis:

[281 Pages Report] The global specialty PACS market size is projected to reach USD 3.5 billion in 2024 from USD 2.6 billion in 2019, at a CAGR of 6.0%.

Browse and in-depth TOC on "Specialty PACS Market"

148 – Tables
124 – Figures
181 – Pages

The on-premise model segment accounted for the largest share of the specialty PACS market in 2018

Based on the deployment model, the Orthopedics PACS Market is segmented into on-premise and web/cloud-based specialty PACS. The on-premise segment is expected to account for the largest share of the Orthopedics PACS Market. This can be attributed to the easily customizable nature of on-premise solutions, as compared to web/cloud-based specialty PACS.

Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=66166054

The hospital segment accounted for the largest share in 2018 and is expected to be the fastest-growing end-user of the specialty PACS market

Based on the end-user, the medical market is segmented into hospitals, ambulatory surgery centers (ASCs) & clinics, diagnostic imaging centers, and other end-users. The rising patient population, growing awareness about the benefits of early disease diagnosis, technological advancements in imaging modalities, increasing digitization of patient data, and rapid growth in EMR adoption are some significant factors responsible for the large share and fastest growth of this segment during the forecast period.

North America dominated the Orthopedics PACS Market in 2018

In 2018, North America commanded the largest share of the Orthopedics PACS Market due to factors such as increasing medical imaging volumes and several diagnostic imaging centers, growing geriatric population, and the fast adoption of technologically advanced imaging systems. However, Asia Pacific is expected to grow at the highest CAGR during the forecast period. Factors such the increasing incidence of chronic diseases, rising awareness on the benefits of early disease diagnosis, and growing adoption of imaging modalities are some of the factors driving the growth of Orthopedics PACS Market in this region.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Key Market Players:

The key players operating in the global Specialty PACS Market are IBM Corporation (Merge Healthcare Incorporated) (US),  McKesson Corporation (US), Agfa Healthcare (Belgium), Carestream Health (a part of Onex Corporation) (Canada), Philips Healthcare (Netherlands), Sectra AB (Sweden), Siemens Healthineers (Germany), Novarad  (US), INFINITT North America (US), Intelerad Medical Systems (Canada), Topcon Corporation (Japan), Sonomed Escalon (US), Canon USA, Inc. (US) (a subsidiary of Canon Inc.), Visbion (UK), and EyePACS, LLC (US).

The research study involves four major activities in estimating the current market size for CRISPR technology. Exhaustive secondary research was conducted to collect information on the market as well as its peer and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both the top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=134401204

Major Market Growth Drivers:

The rise in the availability of government and private funding and the adoption of CRISPR technology are the key factors driving the growth of CRISPR Services Market.

Revenue Growth Analysis:

[163Pages Report] The CRISPR technology market is expected to grow from USD 562 million in 2018 to USD 1,715 million by 2023, at a CAGR of 25% during the forecast period.

Browse and in-depth TOC on "CRISPR Technology Market "

132 – Tables
24 – Figures
163 – Pages

By product and service, the CRISPR services segment is expected to be the fastest-growing in the CRISPR technology market during the forecast period.

The services segment forms the fastest-growing segment in the market, by product and service. Based on service, the CRISPR services market is segmented into gRNA design and vector construction, cell line engineering, screening services, and other CRISPR services (mediated transcriptome editing and epigenome editing services). The cell line engineering services segment is expected to grow at the highest rate.

Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=134401204

By application, the biomedical applications segment accounted for the largest share during the forecast period.

The major biomedical applications of CRISPR include gene therapy, drug discovery, and diagnostics. Across the globe, various gene therapy clinical trials are currently underway. These factors are expected to drive the adoption of CRISPR technology in this segment. In drug discovery applications, CRISPR is used to develop more physiologically relevant models (cell lines and animal models) that correlate better to the clinical setting and thereby reduce drug candidate failure in the initial steps. The ability to modify endogenous genes can help to study the effect of drugs on targets along with endogenous proteins, rather than having to rely on overexpression.

North America is expected to account for the largest CRISPR Products Market share during the forecast period.

North America is estimated to account for the largest share of the CRISPR Products Market in 2018. This is majorly attributed to the rising government and private funding, presence of major pharma and gene therapy companies, and the adoption of CRISPR in several applications. Furthermore, crops that are treated with CRISPR-based gene editing are not considered as GMOs in US; this has attracted a number of agricultural companies to focus on the commercialization of CRISPR-edited crops.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Key CRISPR Services Market Players:

The key players operating in the global CRISPR Services Market are Cellecta, Inc. (US), Thermo Fisher (US), GeneCopoeia, Inc. (US), Applied StemCell (US), Synthego Corporation (US), OriGene Technologies (US), Horizon Discovery (UK), Merck (Germany), and GenScript (US).

[338 Pages Report] The cleanroom technologies market is projected to reach USD 7.3 billion by 2025 from USD 5.1 billion in 2020, at a CAGR of 7.2% during the forecast period.

The growth of healthcare Cleanroom Market is majorly driven by the stringent regulatory framework, growth of the biologics sector, rising demand for sterilized pharmaceutical formulations, increasing demand for medical devices, and technological advancements in cleanroom technology. Also, the increasing demand in developing economies and the growing focus on energy-efficient cleanrooms are expected to offer significant opportunities for market growth in the coming years. However, the high operational cost associated with the cleanrooms is expected to restrain market growth to a certain extent.

Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=263122482

The consumables segment accounts for the largest share of the healthcare Cleanroom Market, by product, in 2019

Based on product, the cleanroom technology market is segmented into consumables, equipment, and controls. The consumables segment accounted for the larger market share in 2019. The high and growing number of pharmaceutical, biotech, and medical device companies facilitating the use of disposable protective clothing has resulted in the increased adoption of the consumables in the cleanroom technologies market. Also, the large number of R&D activities in the healthcare industry is resulting in a stable demand for cleanroom consumables among end users.

Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=263122482

The pharmaceutical industry end-user segment is expected to account for the largest share of the Cleanroom consumables market in 2019

The pharmaceutical industry end-user segment accounted for the largest share of the Cleanroom consumables market in 2019. This is attributed to the industrial growth in this sector, the robust pipeline of injectable formulations, and rising focus on ensuring the quality of healthcare products.

North America is expected to hold the largest share for players operating in the cleanroom technology market

North America accounted for the largest share of the cleanroom technology market in 2019. Factors such as stringent regulatory standards for product approvals, technological advancements in cleanrooms, initiatives taken by private organizations to create awareness regarding cleanrooms, and growth of the healthcare sector on a global scale are among the few factors expected to contribute to the growth of this market.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Key Market Players:

The key players operating in the global Cleanroom Technologies Market are Azbil Corporation (Japan), Kimberly-Clark Corporation (US), Ardmac (Ireland), Clean Air Products (US), Labconco Corporation (US), Dynarex Corporation (US), DowDuPont Inc. (US), Illinois Tool Works Inc. (US), Taikisha Ltd. (Japan), Exyte AG (Germany), COLANDIS GmbH (Germany), ABN Cleanroom Technology (Belgium), Clean Rooms International, Inc. (US), Bouygues Group (France), Terra Universal, Inc. (US), Connect 2 Cleanrooms Ltd (UK), Camfil (Sweden), OCTANORM-Vertriebs-GmbH (Germany), Parteco Srl (Italy), and Airtech Japan, Ltd. (Japan)